Clinical Assessment And Treatment Preferences of Physiotherapists Working in Neurorehabilitation: A Research From Turkey

NCT05855096 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 95

Last updated 2024-02-14

No results posted yet for this study

Summary

The most common neurological diseases are stroke, Multiple Sclerosis and Parkinson's. Neurorehabilitation is a process that aims to improve the quality of life by minimizing the functional disorders caused by the motor and sensory effects of the problems in the nervous system. A detailed and accurate evaluation and an effective treatment program are required for successful neurorehabilitation. There is no common perspective on evaluation and treatment methods used in the field of neurorehabilitation.The aim of this study is to establish a standard perspective by determining the most preferred evaluation and treatment methods by physiotherapists working in the field of neurorehabilitation in our country. This perspective will help to establish a common understanding in the field of neurorehabilitation and to have knowledge of the different methods used by all physiotherapists working in this field. In this way, the treatment process of the patients will become more effective, and the results obtained from the treatment will be reflected positively. This study will be a resource showing the evaluation methods and preferences of physiotherapists working in the field of neurorehabilitation in Turkey.

Conditions

  • Neurorehabilitation
  • Physiotherapist
  • Clinical Assessment
  • Treatment Preferences

Interventions

OTHER

Google Form Questionnaire

Google form questionnaire is performed by responders.

Sponsors & Collaborators

  • Biruni University

    lead OTHER

Principal Investigators

  • Guzin Kaya Aytutuldu · Biruni University

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-17
Primary Completion
2023-04-24
Completion
2023-05-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05855096 on ClinicalTrials.gov